Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Left Atrial Fibrosis in Mitral Valve Repair Surgery (ALIVE Trial)

NCT05345730 is registered in ClinicalTrials.gov with Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) as lead sponsor.

NCT NCT05345730
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05345730 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Left Atrial Fibrosis in Mitral Valve Repair Surgery (ALIVE Trial)
Lead sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase
Observational
Overall status
Completed
Start date
February 2, 2022
Completion date
December 31, 2023
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac valve disease, mitral regurgitation, mitral valve disease, mitral valve repair, mitral valve surgery, surgery